Zotefoams plc

As of June 30, 2026, Zotefoams plc carries a market capitalization of 21.69B, placing it among publicly traded companies globally. Its enterprise value stands at 26.64B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Zotefoams plc's next confirmed earnings release is scheduled for March 23, 2027.

As of June 30, 2026, Zotefoams plc has 49.30M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Zotefoams plc maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Zotefoams plc's stock has gained approximately 7.65% over the past 52 weeks. The 50-day moving average sits at 447.34, while the 200-day moving average is 421.24.

As of June 30, 2026, Zotefoams plc holds 1.30B in cash and equivalents against 6.25B in total debt, resulting in a net debt position of 3.91B. Total book value stands at 13.91B, with working capital of 568.60M providing operational flexibility.